Endothelin-3 stimulates the hypothalamic-pituitary-adrenal axis

Area of Science:

• Neuroendocrinology
• Peptide signaling
• Stress response pathways

Background:

• Endothelin-3 (ET-3) is a novel vasoconstrictive peptide found in the central nervous system.
• The physiological roles of ET-3, particularly in neuroendocrine regulation, are not fully understood.

Purpose of the Study:

• To investigate the potential role of Endothelin-3 (ET-3) in regulating the hypothalamic-pituitary-adrenal (HPA) axis.
• To determine if ET-3 influences the release of adrenocorticotropic hormone (ACTH) and corticosterone.

Main Methods:

• Administered ET-3 intravenously to freely moving rats.
• Pretreated rats with a corticotropin-releasing hormone (CRH) antagonist.
• Assessed plasma levels of ACTH and corticosterone.
• Examined the direct effect of ET-3 on cultured anterior pituitary cells.

Main Results:

• Intravenous ET-3 administration significantly increased plasma ACTH and corticosterone levels in rats.
• The effects of ET-3 on ACTH and corticosterone release were significantly reduced by CRH antagonist pretreatment.
• ET-3 did not directly stimulate ACTH release or potentiate CRH action on cultured pituitary cells.

Conclusions:

• ET-3 likely functions as a neuropeptide within the central nervous system.
• ET-3 activates the HPA axis, leading to ACTH and corticosterone release, primarily through the stimulation of CRH neurons.
• These findings highlight a novel signaling pathway involved in the mammalian stress response.